Literature DB >> 32572265

Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes.

Farshad Nassiri1,2, Ankur Chakravarthy3, Shengrui Feng3,4, Shu Yi Shen3, Romina Nejad1, Jeffrey A Zuccato1,2, Mathew R Voisin1,2, Vikas Patil1, Craig Horbinski5,6, Kenneth Aldape1,7, Gelareh Zadeh8,9, Daniel D De Carvalho10,11.   

Abstract

Definitive diagnosis of intracranial tumors relies on tissue specimens obtained by invasive surgery. Noninvasive diagnostic approaches provide an opportunity to avoid surgery and mitigate unnecessary risk to patients. In the present study, we show that DNA-methylation profiles from plasma reveal highly specific signatures to detect and accurately discriminate common primary intracranial tumors that share cell-of-origin lineages and can be challenging to distinguish using standard-of-care imaging.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32572265      PMCID: PMC8500275          DOI: 10.1038/s41591-020-0932-2

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  54 in total

Review 1.  Clinical application of circulating tumor DNA in breast cancer.

Authors:  Jeffrey Chun Hin Chan; James Chung Hang Chow; Connie Hoi Man Ho; Therese Yue Man Tsui; William C Cho
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-24       Impact factor: 4.553

Review 2.  DNA methylation-based predictors of health: applications and statistical considerations.

Authors:  Paul D Yousefi; Matthew Suderman; Ryan Langdon; Oliver Whitehurst; George Davey Smith; Caroline L Relton
Journal:  Nat Rev Genet       Date:  2022-03-18       Impact factor: 53.242

3.  Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated.

Authors:  Sybren L N Maas; Damian Stichel; Thomas Hielscher; Philipp Sievers; Anna S Berghoff; Daniel Schrimpf; Martin Sill; Philipp Euskirchen; Christina Blume; Areeba Patel; Helin Dogan; David Reuss; Hildegard Dohmen; Marco Stein; Annekathrin Reinhardt; Abigail K Suwala; Annika K Wefers; Peter Baumgarten; Franz Ricklefs; Elisabeth J Rushing; Melanie Bewerunge-Hudler; Ralf Ketter; Jens Schittenhelm; Zane Jaunmuktane; Severina Leu; Fay E A Greenway; Leslie R Bridges; Timothy Jones; Conor Grady; Jonathan Serrano; John Golfinos; Chandra Sen; Christian Mawrin; Christine Jungk; Daniel Hänggi; Manfred Westphal; Katrin Lamszus; Nima Etminan; Gerhard Jungwirth; Christel Herold-Mende; Andreas Unterberg; Patrick N Harter; Hans-Georg Wirsching; Marian C Neidert; Miriam Ratliff; Michael Platten; Matija Snuderl; Kenneth D Aldape; Sebastian Brandner; Jürgen Hench; Stephan Frank; Stefan M Pfister; David T W Jones; Guido Reifenberger; Till Acker; Wolfgang Wick; Michael Weller; Matthias Preusser; Andreas von Deimling; Felix Sahm
Journal:  J Clin Oncol       Date:  2021-10-07       Impact factor: 44.544

4.  Methylation extends the reach of liquid biopsy in cancer detection.

Authors:  Wenyuan Li; Xianghong Jasmine Zhou
Journal:  Nat Rev Clin Oncol       Date:  2020-11       Impact factor: 66.675

5.  Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning.

Authors:  Naixin Liang; Bingsi Li; Ziqi Jia; Chenyang Wang; Pancheng Wu; Tao Zheng; Yanyu Wang; Fujun Qiu; Yijun Wu; Jing Su; Jiayue Xu; Feng Xu; Huiling Chu; Shuai Fang; Xingyu Yang; Chengju Wu; Zhili Cao; Lei Cao; Zhongxing Bing; Hongsheng Liu; Li Li; Cheng Huang; Yingzhi Qin; Yushang Cui; Han Han-Zhang; Jianxing Xiang; Hao Liu; Xin Guo; Shanqing Li; Heng Zhao; Zhihong Zhang
Journal:  Nat Biomed Eng       Date:  2021-06-15       Impact factor: 25.671

6.  Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification.

Authors:  Cecile L Maire; Marceline M Fuh; Kerstin Kaulich; Krystian D Fita; Ines Stevic; Dieter H Heiland; Joshua A Welsh; Jennifer C Jones; André Görgens; Tammo Ricklefs; Lasse Dührsen; Thomas Sauvigny; Simon A Joosse; Guido Reifenberger; Klaus Pantel; Markus Glatzel; Andras G Miklosi; James H Felce; Marco Caselli; Valerio Pereno; Rudolph Reimer; Hartmut Schlüter; Manfred Westphal; Ulrich Schüller; Katrin Lamszus; Franz L Ricklefs
Journal:  Neuro Oncol       Date:  2021-07-01       Impact factor: 12.300

7.  Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon.

Authors:  Emilie Darrigues; Benjamin W Elberson; Annick De Loose; Madison P Lee; Ebonye Green; Ashley M Benton; Ladye G Sink; Hayden Scott; Murat Gokden; John D Day; Analiz Rodriguez
Journal:  Front Oncol       Date:  2021-04-26       Impact factor: 6.244

Review 8.  Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors.

Authors:  Severa Bunda; Jeffrey A Zuccato; Mathew R Voisin; Justin Z Wang; Farshad Nassiri; Vikas Patil; Sheila Mansouri; Gelareh Zadeh
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 9.  Integrated Analysis of Whole Genome and Epigenome Data Using Machine Learning Technology: Toward the Establishment of Precision Oncology.

Authors:  Ken Asada; Syuzo Kaneko; Ken Takasawa; Hidenori Machino; Satoshi Takahashi; Norio Shinkai; Ryo Shimoyama; Masaaki Komatsu; Ryuji Hamamoto
Journal:  Front Oncol       Date:  2021-05-12       Impact factor: 6.244

Review 10.  Emerging Technologies for Non-invasive Monitoring of Treatment Response to Immunotherapy for Brain Tumors.

Authors:  Dimitrios Mathios; Siddhartha Srivastava; Timothy Kim; Chetan Bettegowda; Michael Lim
Journal:  Neuromolecular Med       Date:  2021-07-23       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.